IL160967A0 - Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome - Google Patents

Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome

Info

Publication number: IL160967A0
Authority: IL; Israel
Prior art keywords: treatment; receptor agonists; acetylcholine receptor; nicotinic acetylcholine; restless legs
Prior art date: 2001-10-31

Application number

IL16096702A

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-31

Filing date

2002-10-21

Publication date

2004-08-31

2002-10-21 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-08-31 Publication of IL160967A0 publication Critical patent/IL160967A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Other In-Based Heterocyclic Compounds (AREA)

IL16096702A 2001-10-31 2002-10-21 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome IL160967A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33481001P	2001-10-31	2001-10-31
US33585801P	2001-11-26	2001-11-26
PCT/IB2002/004379 WO2003037329A1 (en)	2001-10-31	2002-10-21	Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome

Publications (1)

Publication Number	Publication Date
IL160967A0 true IL160967A0 (en)	2004-08-31

Family

ID=26989404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16096702A IL160967A0 (en)	2001-10-31	2002-10-21	Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome

Country Status (14)

Country	Link
EP (1)	EP1439836A1 (en)
JP (1)	JP2005507411A (en)
KR (1)	KR20050038583A (en)
CN (1)	CN1568184A (en)
BR (1)	BR0213696A (en)
CA (1)	CA2460118A1 (en)
CZ (1)	CZ2004524A3 (en)
HU (1)	HUP0401967A2 (en)
IL (1)	IL160967A0 (en)
MX (1)	MXPA04002539A (en)
PL (1)	PL370549A1 (en)
SK (1)	SK1912004A3 (en)
TW (1)	TW200300139A (en)
WO (1)	WO2003037329A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004103372A1 (en) *	2003-05-20	2004-12-02	Pfizer Products Inc.	Pharmaceutical compositions of varenicline
CA2538802C (en)	2003-09-17	2015-01-27	Xenoport, Inc.	Treating or preventing restless legs syndrome using prodrugs of gaba analogs
SI1934174T1 (en)	2005-10-07	2011-08-31	Exelixis Inc	Azetidines as mek inhibitors for the treatment of proliferative diseases
AU2007334402B2 (en)	2006-12-14	2014-02-13	Exelixis, Inc.	Methods of using MEK inhibitors
EP3417862B1 (en) *	2012-07-27	2021-05-05	Neurodyn Life Sciences Inc.	Enhanced brain bioavailability of galantamine by selected formulations and transmucosal administration of lipophilic prodrugs
ES2880399T3 (en)	2012-07-27	2021-11-24	Neurodyn Life Sciences Inc	Improved cerebral bioavailability of galantamine through selected formulations and transmucosal administration of lipophilic prodrugs
BR112015008113B1 (en)	2012-10-12	2022-05-24	Exelixis, Inc.	New process to prepare compounds for use in cancer treatment
WO2016188932A2 (en)	2015-05-22	2016-12-01	Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)	Combination compositions and their use in methods for treating obesity and obesity-related disorders
WO2018236957A1 (en) *	2017-06-20	2018-12-27	Nexien Biopharma, Inc.	METHOD AND COMPOSITIONS FOR TREATING REST-FREE LEG SYNDROME

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6020335A (en) *	1997-02-06	2000-02-01	Pfizer Inc	(N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
US5977131A (en) *	1997-04-09	1999-11-02	Pfizer Inc.	Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
US6605610B1 (en) *	1997-12-31	2003-08-12	Pfizer Inc	Aryl fused azapolycyclic compounds
EP0955301A3 (en) *	1998-04-27	2001-04-18	Pfizer Products Inc.	7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
WO1999055680A1 (en) *	1998-04-29	1999-11-04	Pfizer Products Inc.	Aryl fused azapolycyclic compounds

2002
- 2002-10-21 PL PL02370549A patent/PL370549A1/en not_active Application Discontinuation
- 2002-10-21 CZ CZ2004524A patent/CZ2004524A3/en unknown
- 2002-10-21 EP EP02802239A patent/EP1439836A1/en not_active Withdrawn
- 2002-10-21 CN CNA028200292A patent/CN1568184A/en active Pending
- 2002-10-21 SK SK191-2004A patent/SK1912004A3/en not_active Application Discontinuation
- 2002-10-21 CA CA002460118A patent/CA2460118A1/en not_active Abandoned
- 2002-10-21 BR BR0213696-1A patent/BR0213696A/en not_active IP Right Cessation
- 2002-10-21 JP JP2003539673A patent/JP2005507411A/en active Pending
- 2002-10-21 MX MXPA04002539A patent/MXPA04002539A/en unknown
- 2002-10-21 HU HU0401967A patent/HUP0401967A2/en unknown
- 2002-10-21 IL IL16096702A patent/IL160967A0/en unknown
- 2002-10-21 KR KR1020047006544A patent/KR20050038583A/en not_active Ceased
- 2002-10-21 WO PCT/IB2002/004379 patent/WO2003037329A1/en not_active Ceased
- 2002-10-30 TW TW091132199A patent/TW200300139A/en unknown

Also Published As

Publication number	Publication date
HUP0401967A2 (en)	2005-01-28
PL370549A1 (en)	2005-05-30
KR20050038583A (en)	2005-04-27
SK1912004A3 (en)	2004-09-08
TW200300139A (en)	2003-05-16
JP2005507411A (en)	2005-03-17
EP1439836A1 (en)	2004-07-28
BR0213696A (en)	2004-10-26
CN1568184A (en)	2005-01-19
CA2460118A1 (en)	2003-05-08
WO2003037329A1 (en)	2003-05-08
MXPA04002539A (en)	2004-05-31
CZ2004524A3 (en)	2004-07-14

Similar Documents

Publication	Publication Date	Title
HUP0101954A3 (en)	2002-09-30	Use of cabergoline in the production of pharmaceutical compositions for the treatment of restless legs syndrome
NZ525574A (en)	2004-12-24	New treatments for restless legs syndrome
AU2003274456A8 (en)	2004-04-19	Picnic table
PL377791A1 (en)	2006-02-20	3-amino-piperidine derivatives and processes for their preparation
EP1448669A4 (en)	2005-01-19	Polyimide copolymer and methods for preparing the same
AU2003256869A8 (en)	2004-02-23	Picnic table
DK1307446T3 (en)	2005-08-15	Perfluoroalkyl-containing complexes with sugar residues, process for their preparation and use
IL160967A0 (en)	2004-08-31	Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
IL158254A0 (en)	2004-05-12	Indolinones, substituted in position 6, and their use as kinase inhibitors
EP1487799A4 (en)	2005-06-01	9-aminoacridine derivatives and process for the preparation thereof
EP1537083A4 (en)	2006-11-22	S-(-)-amlodipine nicotinate and process for the preparation thereof
NO20011580D0 (en)	2001-03-28	Powdered mannitol and process for its preparation
GB2375956B (en)	2004-09-15	Chair for infants
GB2372695B (en)	2004-04-07	Improvements in furniture
GB2372248B (en)	2003-12-24	Kiln furniture
GB0114619D0 (en)	2001-08-08	Heated bedstead
HK1072544A (en)	2005-09-02	Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders
GB2362821B (en)	2003-12-03	Furniture apparatus
PL112662U1 (en)	2003-05-05	Upholstered piece of furniture
GB0211677D0 (en)	2002-07-03	Retaining apparatus for use in furniture
IT1311018B1 (en)	2002-02-27	ADJUSTABLE STEM FOR FURNITURE AND TABLES IN PARTICULAR.
TW551085U (en)	2003-09-01	Heat-insulated structure of processing table
TW527880U (en)	2003-04-11	Simple foldable table for picnic use
FI20012565L (en)	2003-06-22	Products used in immunosuppressive therapy
GB0102203D0 (en)	2001-03-14	The bed/table